Viewing Study NCT00364858


Ignite Creation Date: 2025-12-25 @ 12:21 AM
Ignite Modification Date: 2025-12-30 @ 3:39 AM
Study NCT ID: NCT00364858
Status: COMPLETED
Last Update Posted: 2015-04-03
First Post: 2006-08-15
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease
Sponsor: Genzyme, a Sanofi Company
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2001-12
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2007-02
Completion Date Type: ACTUAL
First Submit Date: 2006-08-15
First Submit QC Date: None
Study First Post Date: 2006-08-16
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2009-05-28
Results First Submit QC Date: None
Results First Post Date: 2009-09-02
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2015-03-17
Last Update Post Date: 2015-04-03
Last Update Post Date Type: ESTIMATED